Filing Details
- Accession Number:
- 0000930413-11-007456
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-18 08:48:52
- Reporting Period:
- 2011-11-16
- Filing Date:
- 2011-11-18
- Accepted Time:
- 2011-11-18 08:48:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
316253 | Enzo Biochem Inc | ENZ | Services-Medical Laboratories (8071) | 132866202 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
903568 | Elazar Rabbani | C/O Enzo Biochem, Inc. 527 Madison Avenue New York, NY 10022 | Ceo And Secretary | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.01 Per Share | Acquisiton | 2011-11-16 | 600 | $2.28 | 2,100,889 | No | 4 | P | Direct | |
Common Stock, Par Value $0.01 Per Share | Acquisiton | 2011-11-16 | 6,600 | $2.28 | 2,107,489 | No | 4 | P | Direct | |
Common Stock, Par Value $0.01 Per Share | Acquisiton | 2011-11-16 | 5,700 | $2.29 | 2,113,189 | No | 4 | P | Direct | |
Common Stock, Par Value $0.01 Per Share | Acquisiton | 2011-11-16 | 3,600 | $2.29 | 2,116,789 | No | 4 | P | Direct | |
Common Stock, Par Value $0.01 Per Share | Acquisiton | 2011-11-16 | 2,800 | $2.30 | 2,119,589 | No | 4 | P | Direct | |
Common Stock, Par Value $0.01 Per Share | Acquisiton | 2011-11-16 | 100 | $2.30 | 2,119,689 | No | 4 | P | Direct | |
Common Stock, Par Value $0.01 Per Share | Acquisiton | 2011-11-16 | 600 | $2.30 | 2,120,289 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Includes (i) 239,000 shares of Common Stock issuable upon the exercise of options which are exercisable within 60 days from the date hereof, (ii) 5,547 shares of Common Stock held in the name of the Reporting Person as custodian for certain of his children, (iii) 22,115 shares of Common Stock held in the name of the Reporting Person's wife as custodian for certain of their children, (iv) an aggregate of 5,100 shares of Common Stock held in the name of the Reporting Person's children and (v) 12,502 shares of Common Stock held in the Company's 401(k) plan.